Pirfenidone Tablets Manufacturer in India | Pulmonary Fibrosis Therapy Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Pirfenidone Tablets are antifibrotic medications used in the treatment and management of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disorder characterized by irreversible scarring of lung tissue. The medicine works through antifibrotic, anti-inflammatory, and antioxidant mechanisms that help slow fibroblast proliferation and reduce collagen deposition in the lungs. Genliva Wellness LLP is a trusted Pirfenidone Tablet Manufacturer in India offering high-quality respiratory and specialty care formulations for domestic and international pharmaceutical markets.

Pirfenidone is widely prescribed for patients with progressive pulmonary fibrosis to help preserve lung function and slow disease progression. It is commonly used in long-term respiratory care programs where fibrosis leads to declining oxygen exchange capacity. As a reliable Pirfenidone Tablet Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Pirfenidone Tablets are an important therapeutic option in pulmonary medicine, helping manage fibrotic lung disease through targeted modulation of inflammatory and fibrotic pathways.

Pirfenidone Tablets are formulated to reduce fibrotic activity and support lung function preservation.

Contains Pirfenidone as the active ingredient
Antifibrotic, anti-inflammatory agent
Inhibits fibroblast proliferation
Reduces collagen synthesis in lung tissue
Modulates cytokine-mediated inflammatory pathways
Helps slow progression of pulmonary fibrosis

Pirfenidone Tablets are used in the management of fibrotic lung diseases.

Idiopathic pulmonary fibrosis (IPF)
Progressive pulmonary fibrosis
Chronic interstitial lung disease
Lung scarring conditions
Respiratory function preservation therapy
Long-term pulmonary care management

Pirfenidone Tablets provide targeted antifibrotic action in chronic lung disease.

Helps slow progression of lung fibrosis
Supports preservation of respiratory function
Reduces fibroblast activity in lung tissue
Provides anti-inflammatory effects
Supports long-term IPF management
Improves disease control in pulmonary fibrosis patients